Evidence map›Paper›PMID 42797507›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis.

Omar M Alawad, Norhan Tantawy, Soha Elsalhy, Asmaa A Ahmed, Shahira Nofal, Eman M Raafat

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Omar M AlawadInspection Department, Ministry of Health Branch in Madinah, Madinah 41311, Saudi Arabia.
Norhan TantawyDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Egypt.
Soha ElsalhyDepartment of Pharmaceutics, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza 12585, Egypt.ORCID 0000-0002-3312-8540
Asmaa A AhmedDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Egypt.
Shahira NofalDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Egypt.
Eman M RaafatDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Capital University (Formerly Helwan University), Cairo 11795, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiotensin II type 1 receptorERK1/2methotrexateolmesartanPLGA

Identifiers

PMID42797507

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.